Natera, Inc.
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)
Close on Nov 2, 2026Market cap $54.62BP/E –Yield –
Natera Lease Maturity: Thereafter / After Year 5 by Year
Lease Maturity: Thereafter / After Year 5 ($M) ($M)
Natera Lease Maturity: Thereafter / After Year 5: $51.0M in FY2025, down 4.3% from a year earlier.
Latest, FY2025
51.0
Period ended Dec 31, 2025
Change on a year earlier
-4.3%
53.3 in FY2024
History
7 years
Since FY2019
Sources
7
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (2026-02-27) ↗
Reported in Form 10-K Note — Leases (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Lease Maturity: Thereafter / After Year 5 ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 51.0 | -4.3% | Form 10-K (2026-02-27) ↗ |
| FY2024 | Dec 31, 2024 | 53.3 | +91.0% | Form 10-K (2025-02-28) ↗ |
| FY2023 | Dec 31, 2023 | 27.9 | -17.9% | Form 10-K (2024-02-29) ↗ |
| FY2022 | Dec 31, 2022 | 34.0 | +24.4% | Form 10-K (2023-03-01) ↗ |
| FY2021 | Dec 31, 2021 | 27.3 | +1,098.7% | Form 10-K (2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 2.28 | -51.8% | Form 10-K (2021-02-26) ↗ |
| FY2019 | Dec 31, 2019 | 4.73 | – | Form 10-K (2020-03-02) ↗ |
Cite this data
StockData. (2026). Natera Lease Maturity: Thereafter / After Year 5 ($M), annual FY2019–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/lease-undisc-after-year5
See every metric in the Natera KPI table. Data updated Nov 2, 2026.